B. Akinci Et Al. , "Metreleptin therapy for nonalcoholic steatohepatitis: Open-label therapy interventions in two different clinical settings," MED , vol.2, no.7, pp.814-842, 2021
Akinci, B. Et Al. 2021. Metreleptin therapy for nonalcoholic steatohepatitis: Open-label therapy interventions in two different clinical settings. MED , vol.2, no.7 , 814-842.
Akinci, B., Subauste, A., Ajluni, N., Esfandiari, N. H., Meral, R., Neidert, A. H., ... Eraslan, A.(2021). Metreleptin therapy for nonalcoholic steatohepatitis: Open-label therapy interventions in two different clinical settings. MED , vol.2, no.7, 814-842.
Akinci, Baris Et Al. "Metreleptin therapy for nonalcoholic steatohepatitis: Open-label therapy interventions in two different clinical settings," MED , vol.2, no.7, 814-842, 2021
Akinci, Baris Et Al. "Metreleptin therapy for nonalcoholic steatohepatitis: Open-label therapy interventions in two different clinical settings." MED , vol.2, no.7, pp.814-842, 2021
Akinci, B. Et Al. (2021) . "Metreleptin therapy for nonalcoholic steatohepatitis: Open-label therapy interventions in two different clinical settings." MED , vol.2, no.7, pp.814-842.
@article{article, author={Baris Akinci Et Al. }, title={Metreleptin therapy for nonalcoholic steatohepatitis: Open-label therapy interventions in two different clinical settings}, journal={MED}, year=2021, pages={814-842} }